What's new! CIDG publications August 2020

Two new reviews and one review update are available in Issue 8 of the Cochrane Database of Systematic Reviews.

New COVID-19 Review

Dinnes  J, Deeks  JJ, Adriano  A, Berhane  S, Davenport  C, Dittrich  S, Emperador  D, Takwoingi  Y, Cunningham  J, Beese  S, Dretzke  J, Ferrante di Ruffano  L, Harris  IM, Price  MJ, Taylor-Phillips  S, Hooft  L, Leeflang  MMG, Spijker  R, Van den Bruel  A. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD013705. DOI: 10.1002/14651858.CD013705.

New Cochrane Review

Kay  AW, González Fernández  L, Takwoingi  Y, Eisenhut  M, Detjen  AK, Steingart  KR, Mandalakas  AM. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD013359. DOI: 10.1002/14651858.CD013359.pub2.

Updated Cochrane Reviews

Milligan  R, Daher  A, Villanueva  G, Bergman  H, Graves  PM. Primaquine alternative dosing schedules for preventing malaria relapse in people with   Plasmodium vivax. Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD012656. DOI: 10.1002/14651858.CD012656.pub3.

 

The CIDG editorial base is located at the Liverpool School of Tropical Medicine  in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. 

The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the  United Nations Sustainable Development Goals, particularly malaria, tuberculosis, HIV/AIDS, and neglected tropical diseases. The aims of the CIDG are to impact on policy and research in tropical diseases through the production of high quality and relevant systematic reviews, and to lead developments in review quality improvement and effective dissemination of findings.